Safety and efficacy of zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (magnolia phase 2 study)
Authors
Tedeschi, A.Trotman, J.
Zinzani, P.
Cavallo, F.
Marasca, R.
Liberati, A.
Linton, Kim M
McKay, P.
Hu, B.
Coleman, M.
Ardeshna, K.
Bijou, F.
Marcus, R.
Portell, C.
Thieblemont, C.
Bachy, E.
Costello, R.
Iyengar, S.
Mocikova, H.
Co, M.
Li, X.
Zhou, W.
Cappellini, M.
Tankersley, C.
Huang, J.
Opat, S.
Affiliation
ASST Grande Ospedale Metropolitano Niguarda;Issue Date
2021